808
Views
1
CrossRef citations to date
0
Altmetric
Commentary

Pediatric acute lymphoblastic leukemia: the missing pieces in risk and survival

, &

References

  • Swerdlow SH, Campo E, Harris NL, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC; 2008.
  • Jeha S, Pui CH. Risk adapted treatment of pediatric acute lymphoblastic leukemia. Hematol Oncol Clinic Am 2009;23:973–990.
  • Jamil A, Theil KS, Ruymann FB, et al. TEL/AML-1 gene. Its frequency and prognostic significance in childhood. Leukemia. Cancer Genet Cytogenet2000;122:73–78.
  • Borowitz MJ, Devidas M, Hunger SP, et al. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors:a Children's Oncology Group study. Blood 2008;111:5477–5485.
  • Juarez-Velazquez R, Reyes-Leon A, Salas-Labadia C, et al. Significance of CASP8AP2 and H2AFZ expression in survival and risk of relapse in children with acute lymphoblastic leukemia. Leuk Lymphoma 2014;55:2305–2311.
  • Flotho C, Coustan-Smith E, Pei D, et al. Genes contributing to minimal residual disease in childhood acute lymphoblastic leukemia: prognostic significance of CASP8AP2. Blood 2006;108:1050–1057.
  • Flotho C, Couston-Smith E, Pei D, et al. A set of genes that regulate cell proliferation predicts treatment outcome in childhood acute lymphoblastic leukemia. Blood 2007;110:1271–1277.
  • Jiao Y, Cui L, Gao C, et al. CASP8AP2 is a promising prognostic indicator in pediatric acute lymphoblastic leukemia. Leuk Res 2012; 13:67–71.
  • Mullinghan CG, Su X, Zhang J, et al. Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. N Engl J Med 2009;360:470–480.
  • Perez-Andreu V, Roberts KG, Harvey RC, et al. Inherited GATA3 variants are associated with Ph-like childhood acute lymphoblastic leukemia and risk of relapse. Nat Genet 2013;45:1494–1498.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.